Pacira BioSciences (PCRX) Earnings Date & Reports

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

PCRX is expected to report earnings to fall 36.78% to 57 cents per share on April 30

Pacira BioSciences PCRX Stock Earnings Reports

Q1'25

Est.

$0.58

Q4'24

Beat

by $0.12

Q3'24

Beat

by $0.09

Q2'24

Beat

by $0.20

Q1'24

Est.

$0.62

The last earnings report on February 27 showed earnings per share of 91 cents, beating the estimate of 79 cents. With 77.31K shares outstanding, the current market capitalization sits at 1.36B.

View a ticker or compare two or three

Compare

PCRX